| 词条 | Hippo signaling pathway | ||||||||||||||||||||||||||||||||||||||
| 释义 |
The Hippo signaling pathway, also known as the Salvador/Warts/Hippo pathway, controls organ size in animals through the regulation of cell proliferation and apoptosis. The pathway takes its name from one of its key signaling components—the protein kinase Hippo (Hpo). Mutations in this gene lead to tissue overgrowth, or a "hippopotamus"-like phenotype. A fundamental question in developmental biology is how an organ knows to stop growing after reaching a particular size. Organ growth relies on several processes occurring at the cellular level, including cell division and programmed cell death (or apoptosis). The Hippo signaling pathway is involved in restraining cell proliferation and promoting apoptosis. As many cancers are marked by unchecked cell division, this signaling pathway has become increasingly significant in the study of human cancer.[1] Hippo pathway also has critical role in stem cell and tissue specific progenitor cell self-renewal and expansion.[2] The Hippo signaling pathway appears to be highly conserved. While most of the Hippo pathway components were identified in the fruit fly (Drosophila melanogaster) using mosaic genetic screens, orthologs to these components (genes that function analogously in different species) have subsequently been found in mammals. Thus, the delineation of the pathway in Drosophila has helped to identify many genes that function as oncogenes or tumor suppressors in mammals. MechanismThe Hippo pathway consists of a core kinase cascade in which Hpo phosphorylates the protein kinase Warts (Wts).[3][4] Hpo (MST1/2 in mammals) is a member of the Ste-20 family of protein kinases. This highly conserved group of serine/threonine kinases regulates several cellular processes, including cell proliferation, apoptosis, and various stress responses.[5] Once phosphorylated, Wts (LATS1/2 in mammals) becomes active. Misshapen (Msn, MAP4K4/6/7 in mammals) and Happyhour (Hppy, MAP4K1/2/3/5 in mammals) act in parallel to Hpo to activate Wts.[6][7][8] Wts is a nuclear DBF-2-related kinase. These kinases are known regulators of cell cycle progression, growth, and development.[9] Two proteins are known to facilitate the activation of Wts: Salvador (Sav) and Mob as tumor suppressor (Mats). Sav (WW45 in mammals) is a WW domain-containing protein, meaning that this protein contains a sequence of amino acids in which a tryptophan and an invariant proline are highly conserved.[10] Hpo can bind to and phosphorylate Sav, which may function as a scaffold protein because this Hpo-Sav interaction promotes phosphorylation of Wts.[11] Hpo can also phosphorylate and activate Mats (MOBKL1A/B in mammals), which allows Mats to associate with and strengthen the kinase activity of Wts.[12] Activated Wts can then go on to phosphorylate and inactivate the transcriptional coactivator Yorkie (Yki). Yki is unable to bind DNA by itself. In its active state, Yki binds to the transcription factor Scalloped (Sd), and the Yki-Sd complex becomes localized to the nucleus. This allows for the expression of several genes that promote organ growth, such as cyclin E, which promotes cell cycle progression, and diap1 (Drosophila inhibitor of apoptosis protein-1), which, as its name suggests, prevents apoptosis.[13] Yki also activates expression of the bantam microRNA, a positive growth regulator that specifically affects cell number.[14][15] Thus, the inactivation of Yki by Wts inhibits growth through the transcriptional repression of these pro-growth regulators. By phosphorylating Yki at serine 168, Wts promotes the association of Yki with 14-3-3 proteins, which help to anchor Yki in the cytoplasm and prevent its transport to the nucleus. In mammals, the two Yki orthologs are Yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ).[16] When activated, YAP and TAZ can bind to several transcription factors including p73, Runx2 and several TEADs.[17] YAP regulates the expression of Hoxa1 and Hoxc13 in mouse and human epithelial cells in vivo and in vitro.[18] The upstream regulators of the core Hpo/Wts kinase cascade include the transmembrane protein Fat and several membrane-associated proteins. As an atypical cadherin, Fat (FAT1-4 in mammals) may function as a receptor, though an extracellular ligand has not been positively identified. While Fat is known to bind to another atypical cadherin, Dachsous (Ds), during tissue patterning,[19] it is unclear what role Ds has in regulating tissue growth. Nevertheless, Fat is recognized as an upstream regulator of the Hpo pathway. Fat activates Hpo through the apical protein Expanded (Ex; FRMD6/Willin in mammals). Ex interacts with two other apically-localized proteins, Kibra (KIBRA in mammals) and Merlin (Mer; NF2 in mammals), to form the Kibra-Ex-Mer (KEM) complex. Both Ex and Mer are FERM domain-containing proteins, while Kibra, like Sav, is a WW domain-containing protein.[20] The KEM complex physically interacts with the Hpo kinase cascade, thereby localizing the core kinase cascade to the plasma membrane for activation.[21] Fat may also regulate Wts independently of Ex/Hpo, through the inhibition of the unconventional myosin Dachs. Normally, Dachs can bind to and promote the degradation of Wts.[22] In cancerIn fruitfly, the Hippo signaling pathway involves a kinase cascade involving the Salvador (Sav), Warts (Wts) and Hippo (Hpo) protein kinases.[23] Many of the genes involved in the Hippo signaling pathway are recognized as tumor suppressors, while Yki/YAP/TAZ is identified as an oncogene. YAP/TAZ can reprogram cancer cells into cancer stem cells.[24] YAP has been found to be elevated in some human cancers, including breast cancer, colorectal cancer, and liver cancer.[25][26][27] This may be explained by YAP’s recently defined role in overcoming contact inhibition, a fundamental growth control property of normal cells in vitro and in vivo, in which proliferation stops after cells reach confluence[28] (in culture) or occupy maximum available space inside the body and touch one another. This property is typically lost in cancerous cells, allowing them to proliferate in an uncontrolled manner.[29] In fact, YAP overexpression antagonizes contact inhibition.[30] Many of the pathway components recognized as tumor suppressor genes are mutated in human cancers. For example, mutations in Fat4 have been found in breast cancer,[31] while NF2 is mutated in familial and sporadic schwannomas.[32] Additionally, several human cancer cell lines invoke mutations of the WW45 and MOBK1B proteins.[33][34] However, recent research by Marc Kirschner and Taran Gujral has demonstrated that Hippo pathway components may play a more nuanced role in cancer than previously thought. Hippo pathway inactivation enhanced the effect of 15 FDA-approved oncology drugs by promoting chemo-retention.[35] In another study, the Hippo pathway kinases LATS1/2 were found to suppress cancer immunity in mice.[36] Two venture-backed oncology startups, Vivace Therapeutics and the General Biotechnologies subsidiary Nivien Therapeutics, are actively developing kinase inhibitors targeting the Hippo pathway.[37][38] Regulation of human organ sizeThe heart is the first organ formed during mammalian development. A properly sized and functional heart is vital throughout the entire lifespan. Loss of cardiomyocytes because of injury or diseases leads to heart failure, which is a major cause of human morbidity and mortality. Unfortunately, regenerative potential of the adult heart is limited. The Hippo pathway is a recently identified signaling cascade that plays an evolutionarily conserved role in organ size control by inhibiting cell proliferation, promoting apoptosis, regulating fates of stem/progenitor cells, and in some circumstances, limiting cell size. Research indicates a key role of this pathway in regulation of cardiomyocyte proliferation and heart size. Inactivation of the Hippo pathway or activation of its downstream effector, the Yes-associated protein transcription coactivator, improves cardiac regeneration. Several known upstream signals of the Hippo pathway such as mechanical stress, G-protein-coupled receptor signaling, and oxidative stress are known to play critical roles in cardiac physiology. In addition, Yes-associated protein has been shown to regulate cardiomyocyte fate through multiple transcriptional mechanisms.[39][40] Summary table
References1. ^{{cite journal | vauthors = Saucedo LJ, Edgar BA | title = Filling out the Hippo pathway | journal = Nature Reviews. Molecular Cell Biology | volume = 8 | issue = 8 | pages = 613–21 | date = August 2007 | pmid = 17622252 | doi = 10.1038/nrm2221 }} 2. ^{{cite journal | vauthors = Zhao B, Tumaneng K, Guan KL | title = The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal | journal = Nature Cell Biology | volume = 13 | issue = 8 | pages = 877–83 | date = August 2011 | pmid = 21808241 | pmc = 3987945 | doi = 10.1038/ncb2303 }} 3. ^{{cite journal | vauthors = Pan D | title = The hippo signaling pathway in development and cancer | journal = Developmental Cell | volume = 19 | issue = 4 | pages = 491–505 | date = October 2010 | pmid = 20951342 | pmc = 3124840 | doi = 10.1016/j.devcel.2010.09.011 }} 4. ^{{cite journal | vauthors = Meng Z, Moroishi T, Guan KL | title = Mechanisms of Hippo pathway regulation | journal = Genes & Development | volume = 30 | issue = 1 | pages = 1–17 | date = January 2016 | pmid = 26728553 | pmc = 4701972 | doi = 10.1101/gad.274027.115 }} 5. ^{{cite journal | vauthors = Dan I, Watanabe NM, Kusumi A | title = The Ste20 group kinases as regulators of MAP kinase cascades | journal = Trends in Cell Biology | volume = 11 | issue = 5 | pages = 220–30 | date = May 2001 | pmid = 11316611 | doi = 10.1016/S0962-8924(01)01980-8 }} 6. ^{{cite journal | vauthors = Meng Z, Moroishi T, Mottier-Pavie V, Plouffe SW, Hansen CG, Hong AW, Park HW, Mo JS, Lu W, Lu S, Flores F, Yu FX, Halder G, Guan KL | title = MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway | journal = Nature Communications | volume = 6 | pages = 8357 | date = October 2015 | pmid = 26437443 | pmc = 4600732 | doi = 10.1038/ncomms9357 }} 7. ^{{cite journal | vauthors = Zheng Y, Wang W, Liu B, Deng H, Uster E, Pan D | title = Identification of Happyhour/MAP4K as Alternative Hpo/Mst-like Kinases in the Hippo Kinase Cascade | journal = Developmental Cell | volume = 34 | issue = 6 | pages = 642–55 | date = September 2015 | pmid = 26364751 | pmc = 4589524 | doi = 10.1016/j.devcel.2015.08.014 }} 8. ^{{cite journal | vauthors = Li Q, Li S, Mana-Capelli S, Roth Flach RJ, Danai LV, Amcheslavsky A, Nie Y, Kaneko S, Yao X, Chen X, Cotton JL, Mao J, McCollum D, Jiang J, Czech MP, Xu L, Ip YT | title = The conserved misshapen-warts-Yorkie pathway acts in enteroblasts to regulate intestinal stem cells in Drosophila | journal = Developmental Cell | volume = 31 | issue = 3 | pages = 291–304 | date = November 2014 | pmid = 25453828 | pmc = 4254555 | doi = 10.1016/j.devcel.2014.09.012 }} 9. ^{{cite journal | vauthors = Ma J, Benz C, Grimaldi R, Stockdale C, Wyatt P, Frearson J, Hammarton TC | title = Nuclear DBF-2-related kinases are essential regulators of cytokinesis in bloodstream stage Trypanosoma brucei | journal = The Journal of Biological Chemistry | volume = 285 | issue = 20 | pages = 15356–68 | date = May 2010 | pmid = 20231285 | pmc = 2865264 | doi = 10.1074/jbc.M109.074591 }} 10. ^{{cite journal | vauthors = André B, Springael JY | title = WWP, a new amino acid motif present in single or multiple copies in various proteins including dystrophin and the SH3-binding Yes-associated protein YAP65 | journal = Biochemical and Biophysical Research Communications | volume = 205 | issue = 2 | pages = 1201–5 | date = December 1994 | pmid = 7802651 | doi = 10.1006/bbrc.1994.2793 }} 11. ^{{cite journal | vauthors = Wu S, Huang J, Dong J, Pan D | title = hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts | journal = Cell | volume = 114 | issue = 4 | pages = 445–56 | date = August 2003 | pmid = 12941273 | doi = 10.1016/S0092-8674(03)00549-X }} 12. ^{{cite journal | vauthors = Wei X, Shimizu T, Lai ZC | title = Mob as tumor suppressor is activated by Hippo kinase for growth inhibition in Drosophila | journal = The EMBO Journal | volume = 26 | issue = 7 | pages = 1772–81 | date = April 2007 | pmid = 17347649 | pmc = 1847660 | doi = 10.1038/sj.emboj.7601630 }} 13. ^{{cite journal | vauthors = Huang J, Wu S, Barrera J, Matthews K, Pan D | title = The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP | journal = Cell | volume = 122 | issue = 3 | pages = 421–34 | date = August 2005 | pmid = 16096061 | doi = 10.1016/j.cell.2005.06.007 }} 14. ^{{cite journal | vauthors = Thompson BJ, Cohen SM | title = The Hippo pathway regulates the bantam microRNA to control cell proliferation and apoptosis in Drosophila | journal = Cell | volume = 126 | issue = 4 | pages = 767–74 | date = August 2006 | pmid = 16923395 | doi = 10.1016/j.cell.2006.07.013 }} 15. ^{{cite journal | vauthors = Nolo R, Morrison CM, Tao C, Zhang X, Halder G | title = The bantam microRNA is a target of the hippo tumor-suppressor pathway | journal = Current Biology | volume = 16 | issue = 19 | pages = 1895–904 | date = October 2006 | pmid = 16949821 | doi = 10.1016/j.cub.2006.08.057 }} 16. ^{{cite journal | vauthors = Wang K, Degerny C, Xu M, Yang XJ | title = YAP, TAZ, and Yorkie: a conserved family of signal-responsive transcriptional coregulators in animal development and human disease | journal = Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire | volume = 87 | issue = 1 | pages = 77–91 | date = February 2009 | pmid = 19234525 | doi = 10.1139/O08-114 }} 17. ^{{cite journal | vauthors = Badouel C, Garg A, McNeill H | title = Herding Hippos: regulating growth in flies and man | journal = Current Opinion in Cell Biology | volume = 21 | issue = 6 | pages = 837–43 | date = December 2009 | pmid = 19846288 | doi = 10.1016/j.ceb.2009.09.010 }} 18. ^{{cite journal | vauthors = Liu M, Zhao S, Lin Q, Wang XP | title = YAP regulates the expression of Hoxa1 and Hoxc13 in mouse and human oral and skin epithelial tissues | journal = Molecular and Cellular Biology | volume = 35 | issue = 8 | pages = 1449–61 | date = April 2015 | pmid = 25691658 | pmc = 4372702 | doi = 10.1128/MCB.00765-14 }} 19. ^{{cite journal | vauthors = Cho E, Irvine KD | title = Action of fat, four-jointed, dachsous and dachs in distal-to-proximal wing signaling | journal = Development | volume = 131 | issue = 18 | pages = 4489–500 | date = September 2004 | pmid = 15342474 | doi = 10.1242/dev.01315 }} 20. ^{{cite journal | vauthors = Baumgartner R, Poernbacher I, Buser N, Hafen E, Stocker H | title = The WW domain protein Kibra acts upstream of Hippo in Drosophila | journal = Developmental Cell | volume = 18 | issue = 2 | pages = 309–16 | date = February 2010 | pmid = 20159600 | doi = 10.1016/j.devcel.2009.12.013 }} 21. ^{{cite journal | vauthors = Pan D | title = The hippo signaling pathway in development and cancer | journal = Developmental Cell | volume = 19 | issue = 4 | pages = 491–505 | date = October 2010 | pmid = 20951342 | pmc = 3124840 | doi = 10.1016/j.devcel.2010.09.011 }} 22. ^{{cite journal | vauthors = Cho E, Feng Y, Rauskolb C, Maitra S, Fehon R, Irvine KD | title = Delineation of a Fat tumor suppressor pathway | journal = Nature Genetics | volume = 38 | issue = 10 | pages = 1142–50 | date = October 2006 | pmid = 16980976 | doi = 10.1038/ng1887 }} 23. ^{{cite web | url=https://www.uniprot.org/uniprot/Q45VV3 | title=Yki - Transcriptional coactivator yorkie - Drosophila melanogaster (Fruit fly) - yki gene & protein}} 24. ^{{cite journal | vauthors = Piccolo S, Dupont S, Cordenonsi M | title = The biology of YAP/TAZ: hippo signaling and beyond | journal = Physiological Reviews | volume = 94 | issue = 4 | pages = 1287–312 | date = October 2014 | pmid = 25287865 | doi = 10.1152/physrev.00005.2014 }} 25. ^{{cite journal | vauthors = Kango-Singh M, Singh A | title = Regulation of organ size: insights from the Drosophila Hippo signaling pathway | journal = Developmental Dynamics | volume = 238 | issue = 7 | pages = 1627–37 | date = July 2009 | pmid = 19517570 | doi = 10.1002/dvdy.21996 }} 26. ^{{cite journal | vauthors = Zender L, Spector MS, Xue W, Flemming P, Cordon-Cardo C, Silke J, Fan ST, Luk JM, Wigler M, Hannon GJ, Mu D, Lucito R, Powers S, Lowe SW | title = Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach | journal = Cell | volume = 125 | issue = 7 | pages = 1253–67 | date = June 2006 | pmid = 16814713 | pmc = 3026384 | doi = 10.1016/j.cell.2006.05.030 | authorlink5 = Carlos Cordon-Cardo }} 27. ^{{cite journal | vauthors = Steinhardt AA, Gayyed MF, Klein AP, Dong J, Maitra A, Pan D, Montgomery EA, Anders RA | title = Expression of Yes-associated protein in common solid tumors | journal = Human Pathology | volume = 39 | issue = 11 | pages = 1582–9 | date = November 2008 | pmid = 18703216 | pmc = 2720436 | doi = 10.1016/j.humpath.2008.04.012 }} 28. ^{{cite journal | vauthors = Eagle H, Levine EM | title = Growth regulatory effects of cellular interaction | journal = Nature | volume = 213 | issue = 5081 | pages = 1102–6 | date = March 1967 | pmid = 6029791 | doi = 10.1038/2131102a0 }} 29. ^{{cite journal | vauthors = Hanahan D, Weinberg RA | title = The hallmarks of cancer | journal = Cell | volume = 100 | issue = 1 | pages = 57–70 | date = January 2000 | pmid = 10647931 | doi = 10.1016/S0092-8674(00)81683-9 }} 30. ^{{cite journal | vauthors = Zhao B, Wei X, Li W, Udan RS, Yang Q, Kim J, Xie J, Ikenoue T, Yu J, Li L, Zheng P, Ye K, Chinnaiyan A, Halder G, Lai ZC, Guan KL | title = Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control | journal = Genes & Development | volume = 21 | issue = 21 | pages = 2747–61 | date = November 2007 | pmid = 17974916 | pmc = 2045129 | doi = 10.1101/gad.1602907 }} 31. ^{{cite journal | vauthors = Qi C, Zhu YT, Hu L, Zhu YJ | title = Identification of Fat4 as a candidate tumor suppressor gene in breast cancers | journal = International Journal of Cancer | volume = 124 | issue = 4 | pages = 793–8 | date = February 2009 | pmid = 19048595 | pmc = 2667156 | doi = 10.1002/ijc.23775 }} 32. ^{{cite journal | vauthors = Evans DG, Sainio M, Baser ME | title = Neurofibromatosis type 2 | journal = Journal of Medical Genetics | volume = 37 | issue = 12 | pages = 897–904 | date = December 2000 | pmid = 11106352 | pmc = 1734496 | doi = 10.1136/jmg.37.12.897 }} 33. ^{{cite journal | vauthors = Tapon N, Harvey KF, Bell DW, Wahrer DC, Schiripo TA, Haber D, Hariharan IK | title = salvador Promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines | journal = Cell | volume = 110 | issue = 4 | pages = 467–78 | date = August 2002 | pmid = 12202036 | doi = 10.1016/S0092-8674(02)00824-3 }} 34. ^{{cite journal | vauthors = Lai ZC, Wei X, Shimizu T, Ramos E, Rohrbaugh M, Nikolaidis N, Ho LL, Li Y | title = Control of cell proliferation and apoptosis by mob as tumor suppressor, mats | journal = Cell | volume = 120 | issue = 5 | pages = 675–85 | date = March 2005 | pmid = 15766530 | doi = 10.1016/j.cell.2004.12.036 }} 35. ^{{cite journal | vauthors = Gujral TS, Kirschner MW | title = Hippo pathway mediates resistance to cytotoxic drugs | journal = Proceedings of the National Academy of Sciences of the United States of America | volume = 114 | issue = 18 | pages = E3729-E3738 | date = May 2017 | pmid = 28416665 | pmc = 5422801 | doi = 10.1073/pnas.1703096114 }} 36. ^{{cite journal | vauthors = Moroishi T, Hayashi T, Pan WW, Fujita Y, Holt MV, Qin J, Carson DA, Guan KL | title = The Hippo Pathway Kinases LATS1/2 Suppress Cancer Immunity | journal = Cell | volume = 167 | issue = 6 | pages = 1525–1539.e17 | date = December 2016 | pmid = 27912060 | pmc = 5512418 | doi = 10.1016/j.cell.2016.11.005 }} 37. ^{{cite web |url= http://www.fiercebiotech.com/biotech/vivace-uncloaks-40m-u-s-china-backing-for-cancer-trials |title=Vivace uncloaks with $40M, U.S.-China backing for cancer trials | work = FierceBiotech |access-date=2017-11-04}} 38. ^{{Cite web |url= https://www.crunchbase.com/organization/general-biotechnologies |title=General Biotechnologies |website=Crunchbase |access-date=2017-11-04 }} 39. ^{{cite journal | vauthors = Qin F, Tian J, Zhou D, Chen L | title = Mst1 and Mst2 kinases: regulations and diseases | journal = Cell & Bioscience | volume = 3 | issue = 1 | pages = 31 | date = August 2013 | pmid = 23985272 | pmc = 3849747 | doi = 10.1186/2045-3701-3-31 }} 40. ^{{cite journal | vauthors = Hilman D, Gat U | title = The evolutionary history of YAP and the hippo/YAP pathway | journal = Molecular Biology and Evolution | volume = 28 | issue = 8 | pages = 2403–17 | date = August 2011 | pmid = 21415026 | doi = 10.1093/molbev/msr065 }} Further reading{{refbegin}}
2 : Signal transduction|Animal genes |
||||||||||||||||||||||||||||||||||||||
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。